Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429

[1]  Hongyang Wang,et al.  Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. , 2016, Journal of hepatology.

[2]  Shuhan Sun,et al.  Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1 , 2016, Hepatology.

[3]  M. Beckmann,et al.  Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses , 2016 .

[4]  T. Yamanaka,et al.  Postoperative complications are predictive of poor prognosis in hepatocellular carcinoma. , 2015, The Journal of surgical research.

[5]  H. Koga,et al.  Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study , 2015, Cancer medicine.

[6]  A. Forner,et al.  Hepatocellular carcinoma surveillance with miRNAs. , 2015, The Lancet. Oncology.

[7]  D. Gallie.  Faculty Opinions recommendation of The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. , 2015 .

[8]  C. Kang,et al.  DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. , 2015, Cancer letters.

[9]  Runsheng Chen,et al.  The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. , 2015, Cell stem cell.

[10]  S. Donell,et al.  The microRNA-29 family in cartilage homeostasis and osteoarthritis , 2015, Journal of Molecular Medicine.

[11]  I. Ng,et al.  MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis , 2015, Oncotarget.

[12]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[13]  J. Collins.  Long noncoding RNAs and hepatocellular carcinoma. , 2015, Gastroenterology.

[14]  L. Gravitz.  Liver cancer , 2014, Nature.

[15]  Gaurav Kumar Pandey,et al.  The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. , 2014, Cancer cell.

[16]  F. Rojo,et al.  Deregulation of miR‐200b, miR‐200c and miR‐429 indicates its potential relevant role in patients with colorectal cancer liver metastasis , 2014, Journal of surgical oncology.

[17]  D. Lu,et al.  miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway. , 2014, The American journal of pathology.

[18]  Hongyang Wang,et al.  EGFR has a tumor-promoting role in liver macrophages during hepatocellular carcinoma formation , 2014, Nature Cell Biology.

[19]  Jyh‐Horng Wang,et al.  Denbinobin upregulates miR-146a expression and attenuates IL-1β-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytes , 2014, Journal of Molecular Medicine.

[20]  David T. W. Jones,et al.  Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing , 2014, Nature.

[21]  Shuhan Sun,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[22]  Q. Pan,et al.  RNAi screening with shRNAs against histone methylation-related genes reveals determinants of sorafenib sensitivity in hepatocellular carcinoma cells. , 2014, International journal of clinical and experimental pathology.

[23]  A. Fatica,et al.  Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.

[24]  A. Diehl,et al.  NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.

[25]  R. Qin,et al.  Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis , 2013, British Journal of Cancer.

[26]  S. Dhanasekaran,et al.  The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex , 2013, Nature Genetics.

[27]  Luzhe Sun,et al.  Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer , 2013, Oncogene.

[28]  S. Diederichs,et al.  MALAT1 — a paradigm for long noncoding RNA function in cancer , 2013, Journal of Molecular Medicine.

[29]  Shuhan Sun,et al.  Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. , 2013, Carcinogenesis.

[30]  I. Ng,et al.  Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis , 2012, Hepatology.

[31]  Jiamei Yang,et al.  Clinicopathological Significance of ZEB1 Protein in Patients with Hepatocellular Carcinoma , 2012, Annals of Surgical Oncology.

[32]  Fang Wang,et al.  The histone deacetylase 4/SP1/microrna‐200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma , 2011, Hepatology.

[33]  Jun Yu,et al.  EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. , 2011, Cancer research.

[34]  Jørgen Kjems,et al.  Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer , 2011, International journal of cancer.

[35]  T. Chou,et al.  Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells , 2011, Journal of Molecular Medicine.

[36]  Xiaoying Zhang,et al.  Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. , 2010, Journal of hepatology.

[37]  C. Loddenkemper,et al.  Role of hypoxia-inducible transcription factor 1α for progression and chemosensitivity of murine hepatocellular carcinoma , 2010, Journal of Molecular Medicine.

[38]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[39]  J. Rinn,et al.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.

[40]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[41]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[42]  E. Guccione,et al.  Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive , 2007, Nature.

[43]  R. Shiekhattar,et al.  Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing , 2005, Cell.

[44]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[45]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[46]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[47]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[48]  E. Li,et al.  The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation , 2009, Nature Genetics.

[49]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.